ModerateCaution
Phenytoin depletes folate levels through increased catabolism and impaired absorption, potentially causing megaloblastic anemia. However, folate supplementation may reduce phenytoin levels by enhancing its metabolism, creating a bidirectional interaction that requires careful monitoring.
Recommendation: Folate supplementation (0.5-1mg/day) is generally recommended for patients on phenytoin, but phenytoin levels should be monitored when starting folate. Dose adjustments of phenytoin may be necessary.
ModerateSynergy
Phenytoin is a potent CYP enzyme inducer that accelerates vitamin D catabolism through increased 24-hydroxylase activity. Long-term phenytoin use commonly causes vitamin D deficiency, osteomalacia, and increased fracture risk. Vitamin D supplementation is recommended during chronic therapy.
Recommendation: Supplement with vitamin D3 (1000-4000 IU/day) during long-term phenytoin therapy. Monitor 25-OH vitamin D levels periodically and adjust dosing to maintain adequate levels (>30 ng/mL). Higher doses may be needed than in the general population.
ModerateTiming Sensitive
Calcium can reduce phenytoin absorption if taken simultaneously. While calcium supplementation may be important for patients on phenytoin (which depletes calcium), timing must be managed to avoid impairing drug absorption and seizure control.
Recommendation: Separate phenytoin and calcium supplements by at least 2 hours to avoid absorption interference. Calcium supplementation is still recommended for bone health during phenytoin therapy, just not at the same time as the medication.
ModerateCaution
Both are potent CYP enzyme inducers that affect each other's metabolism. Phenytoin can decrease carbamazepine levels, while carbamazepine can decrease phenytoin levels, making dose optimization challenging.
Recommendation: Monitor serum levels of both drugs closely when used together. Dose adjustments are frequently needed. Therapeutic drug monitoring is essential.
ModerateCaution
Phenytoin depletes folate and folate supplementation may reduce phenytoin levels. This bidirectional interaction requires careful management.
Recommendation: Low-dose folate (400-1000mcg/day) is recommended on phenytoin. Avoid high-dose folate (>5mg) as it may reduce phenytoin levels. Monitor drug levels when adjusting folate.
ModerateSynergy
Phenytoin therapy is associated with lower vitamin B12 levels and higher homocysteine in multiple studies. B12 deficiency can cause anemia, neuropathy, cognitive symptoms, and can compound folate-related problems already known with phenytoin. Risk is higher with long-term use, older age, vegetarian diets, metformin or acid-suppressing therapy, or baseline B12 deficiency.
Recommendation: Ask about periodic B12 testing if you take phenytoin long term or develop numbness, balance problems, fatigue, or macrocytic anemia. Supplement B12 if levels are low or borderline with symptoms. Keep seizure medication dosing unchanged unless your prescriber adjusts it.
ModerateSynergy
Enzyme-inducing antiseizure drugs such as phenytoin have been associated with vitamin B6 deficiency. Low B6 can contribute to neuropathy symptoms and impaired homocysteine metabolism, especially when folate or B12 status is also poor. This is a monitoring and repletion issue, not a reason to stop phenytoin abruptly.
Recommendation: Ask about B-vitamin or homocysteine testing if you take phenytoin long term, especially if you have neuropathy symptoms or cardiovascular risk factors. Use conservative B6 doses unless deficiency is documented and supervised. Do not take chronic high-dose B6 without monitoring because excess B6 can damage nerves.
SeriousTiming Sensitive
Activated charcoal can strongly adsorb phenytoin in the gut and reduce its absorption. In volunteer data, charcoal given immediately after phenytoin almost completely prevented absorption, and multiple-dose charcoal is used clinically to enhance elimination in phenytoin toxicity. Unsupervised charcoal use can therefore lower phenytoin levels and increase seizure risk.
Recommendation: Do not take activated charcoal as a wellness supplement while using phenytoin unless your clinician specifically directs it for poisoning management. If charcoal is unavoidable, separate it from phenytoin by at least 4-6 hours and ask whether a phenytoin level should be checked. Seek care promptly for breakthrough seizures, severe dizziness, or loss of coordination.
NutriStack